Taro OK'D for Generic of Schering Topical
Posted on: Wednesday, 15 March 2006, 18:00 CST
Taro said Wednesday it has been approved to market generic Elocon Lotion, a corticosteroid to treat skin inflammation.
The company said the Food and Drug Administration has given approval to its mometasone furoate topical solution, 0.1 percent lotion for the temporary relief of inflammatory skin conditions.
The topical product is the generic equivalent of Schering-Plough's Elocon lotion, Taro said in a statement.
Taro estimated sales of Elocon in the United States at approximately $9.6 million.
The generic drug maker got tentative FDA approval of the dermatological drug in December 2004.
Source: United Press International
Related Articles
- More than half of Canadian drugs generic
- Ralphs Expands Discounted Generic Drug Program
- Food 4 Less Expands Discounted Generic Drug Program
- Fred Meyer, QFC Introduce $4 Generic Drugs
- Ralphs Introduces $4 Generic Drugs
- Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry Report Now Available
- Research Needed to Develop Generic Drugs
- Teva and Par Cheered By Depression Generics OKs
- FDA Approves Generic AIDs Drug Combo
Rating: 2.5 / 5 (4 votes)
 |
 |
Rate this article:
User Comments (0)
RSS Feeds